OTC · Biotechnology

Acro Biomedical Co., Ltd. (ACBM) Stock

$0.03 +0.00% OTC: ACBM Healthcare

Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements.

Valuation

MetricValue
Price$0.03
Market Cap$1.56M
P/E Ratio-11.30
P/B Ratio-3.65
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.10
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE34.42%
ROA—
ROCE48.07%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.88
Current Ratio0.01

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$0$0$0
Operating Profit$-8.0M$-16.0M$-9.0M$0$0
Net Profit$-8.0M$-16.0M$-9.0M$0$0
EPS$-0.14$-0.26$-0.15$0.00$0.00
Op Margin-642.5%-2410.0%———

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$1.0M$0$0$0
Total Liabilities$0$0$0$0$0
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.11
EV / EBITDA-9.41
FCF Yield-14.32%
Quick Ratio0.01
Interest Coverage-18.19
Return 1Y3614.29%
Return 3Y-97.74%
Return 5Y—

Ownership

Insiders Held49.97%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMBSAmarantus BioScience Holdings, Inc. $0.00 — -0.01 $36841 0.00%
BSSPBaseline Productions, Inc. $0.00 — -0.02 $74377 0.00%
HDVYHealth Discovery Corporation $0.00 — -0.05 $41171 0.00%
IBXGiBX Group, Inc. $0.00 — — $1975 0.00%
IGRWInteractive Health Network $0.00 — 0.20 $39815 0.00%

About Acro Biomedical Co., Ltd.

Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements. The company offers products such as cordycepin and powdered cordyceps, which come from a type of fungus traditionally utilized in Chinese medicinal practices. Originally founded in 2014, the organization was known as Killer Waves Hawaii, Inc. until it rebranded as Acro Biomedical Co., Ltd. in January 2017. Its operations are headquartered in Fishers, Indiana.

Acro Biomedical Co., Ltd. is headquartered in US.

Acro Biomedical Co., Ltd. (ACBM) stock trades at $0.03 with a market capitalization of $1.56M. The stock is valued at a price-to-earnings (P/E) ratio of -11.30, price-to-book of -3.65, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.10, and currently trades 70.0% below its 52-week high.

On profitability, Acro Biomedical Co., Ltd. generates a return on equity (ROE) of 34.42% — well above the market average, a sign of a high-quality business, return on capital employed of 48.07%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: acrobiomedicalco.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides